ask="4.9100"
ask_size="9700"
average_daily_volume="60410"
bid="2.8000"
bid_size="500"
book_value="1.1920"
change="-0.0402"
change_from_200_day_moving_average="-0.8920"
change_from_50_day_moving_average="-0.2784"
change_from_52_week_high="-3.1152"
change_From_52_week_low="0.4398"
change_in_percent="-1.1824%"
close="3.3598"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.8990"
ebitda="-15.74M"
eps_estimate_current_year="-3.7100"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-2.8100"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.5400"
high_52_weeks="6.4750"
last_trade_date="1/12/2017"
last_trade_price="3.3598"
last_trade_size="271"
last_trade_time="2:33pm"
low="3.3100"
low_52_weeks="2.9200"
market_capitalization="21.15M"
moving_average_200_day="4.2518"
moving_average_50_day="3.6382"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.0000"
open="3.4600"
pe_ratio="N/A"
peg_ratio="-0.0200"
percent_change_from_200_day_moving_average="-20.9797%"
percent_change_from_50_day_moving_average="-7.6516%"
percent_change_from_52_week_high="-48.1112%"
percent_change_from_52_week_low="+15.0616%"
previous_close="3.4000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.8523"
price_per_sales="23.6374"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="3.8400"
stock_exchange="NCM"
symbol="MBVX"
volume="4867"
weeks_range_52="2.9200 - 6.4750"
